(Q31804134)

English

Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 July 2017

Usefulness of Nisoldipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). NIsoldipine in COronary artery disease in LEuven (English)

1 reference

Europe PubMed Central

3 July 2017

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Dens JA

1

1 reference

Europe PubMed Central

3 July 2017

Desmet WJ

2

1 reference

Europe PubMed Central

3 July 2017

Coussement P

3

1 reference

Europe PubMed Central

3 July 2017

De Scheerder IK

4

1 reference

Europe PubMed Central

3 July 2017

Kostopoulos K

5

1 reference

Europe PubMed Central

3 July 2017

Kerdsinchai P

6

1 reference

Europe PubMed Central

3 July 2017

Supanantaroek C

7

1 reference

Europe PubMed Central

3 July 2017

Piessens JH

8

1 reference

Europe PubMed Central

3 July 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

3 July 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

3 July 2017

87

1 reference

Europe PubMed Central

3 July 2017

28-33

1 reference

Europe PubMed Central

3 July 2017

1

1 reference

Europe PubMed Central

3 July 2017

Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Restenosis revisited: insights provided by quantitative coronary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Possible uses of gene therapy in reducing coronary restenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Effects of diltiazem on complications and restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Intra- and interobserver variability of a fast on-line quantitative coronary angiographic system.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

In vivo comparison of different quantitative edge detection systems used for measuring coronary arterial diameters.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Comparison of diltiazem and nifedipine alone and in combination in patients with coronary artery spasm

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter Euro

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angio

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Medical therapy after successful percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901267-4

7 January 2021

Identifiers

10.1016/S0002-9149(00)01267-4

1 reference

Europe PubMed Central

3 July 2017

1 reference

Europe PubMed Central

3 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31804134&oldid=1542409612"